22 October 2026
P&G beats forecasts as shoppers start buying more Tide and Febreze again
Procter & Gamble earned $2.00 a share on an adjusted basis against $1.88 expected, and its sales volume grew 2.4%. The shares rose more than 5% on Thursday morning.
Procter & Gamble, the company behind Tide, Pampers, Gillette and Crest, opened its new financial year with something it has rarely managed lately: people bought more of its products, not just the same amount at higher prices. Results for the three months to September 30 beat forecasts on profit and sales, and the stock climbed more than 5% in Thursday morning trading.
What happened
P&G earned $2.00 a share on an adjusted basis, which leaves out restructuring costs and other one-off items. Analysts surveyed by LSEG had pencilled in $1.88. Sales rose 4% to $23.3 billion, above the $22.8 billion expected. On the standard accounting measure, net income was $4.73 billion, slightly below the $4.75 billion of a year earlier, yet earnings per share still edged up to $1.97 from $1.95 because that profit was split across fewer shares.
The figure management cared about most was volume, meaning the number of units shipped rather than the price charged for them. It grew 2.4%. Across all of fiscal 2026, P&G posted volume growth in only one quarter, as households squeezed the last drop out of every bottle and switched to value packs.
- Fabric and home care (Tide, Febreze) led, with volume up 4.3% on stronger laundry detergent sales.
- Baby, feminine and family care and beauty each grew volume by more than 2%.
- Grooming (Gillette and Venus razors) slipped 0.4%.
- Health care was weakest, down 2.9%, as fewer people bought items like Crest toothpaste and Pepto-Bismol.
Why it matters
P&G is one of the best windows into how ordinary American households are coping. Finance chief Andre Schulten told CNBC the company still sees a two-speed economy: better-off shoppers will happily trade up to something new, even a $30 shampoo, while people on tight budgets are trying to stretch their Tide and Pampers further. P&G is chasing both groups at once, with promotions and new pack sizes for one and pricier launches such as Pampers Amore for the other. Schulten called the competition "intense" and said P&G will still raise prices, but tie increases to new and better products.
For scale, P&G's filings show about $87 billion of sales and $16 billion of net income over the twelve months to June, and the company was worth roughly $370 billion going into the report.
What to watch
P&G kept its full-year forecast for core earnings per share at $6.89 to $7.11. It raised its expected total sales growth to 2% to 4%, from 1% to 3%, a change it put down to buying supplements brand Thorne, a deal that closed on October 1. CEO Shailesh Jejurikar said the company is on track despite continued geopolitical and economic challenges.
- Whether volume keeps growing next quarter, after only one positive quarter last year.
- How much Thorne adds to sales now that it is part of the group.
- Whether health care and grooming volumes turn around.
P&G's full financials are on its Noorult company page.
The companies in this story
Based on reporting by CNBC: Procter & Gamble (PG) Q1 2027 earnings. Facts, not advice.
More news
- Anthropic's IPO, in numbers: 825 million shares at $70 to $78, and a $1.4 trillion price tag
- Trump says the Nvidia scandal didn't endanger US security, and stands by Lutnick
- Nvidia's first earnings without Huang: what Kress will be asked on Tuesday
- Buffett gives away $5.5 billion of Berkshire stock in his Thanksgiving letter
- Banks are using AI to trim back offices. Proof that it adds revenue is harder to find
- IMF chief says the world economy leans too hard on AI as circular deals top $1 trillion